We are proactive in expanding the application of our respiratory care solutions developed by various research activities in order to help more patients.

This effort will allow us to expand our top-notch technologies to both hospital and homecare sectors with the presentation of various evidences on how the demographic and environmental changes have effects on respiration and health of the mankind.
MEKICS has a strong belief that product safety and quality of raw materials must in no way be compromised.

To this end, we have established internal systems and R&D bases satisfying the quality and safety standards for the functionality of respiratory care products. Those help us correctively understand overseas local market circumstances and build a technologically cooperative agent system, thereby contributing to MEKICS evolving into a global player in the respiration care market.

Despite a short history, I’m convinced that we have attained significant performances in the medical equipment market for serious patients.

Starting with leading the technology for patient monitors in Korea, MEKICS has become the first Korean company to develop ventilators and CPAP (Continuous Positive Airway Pressure) for home. We also succeeded in developing software-type high-frequency ventilation technology and commercializing a world-class combined ventilator. As a result, MEKICS has grown to be the only company that can produce ventilators and respiratory care devices in Asia.

MEKICS is a promising young enterprise who pioneers a new future.

Without being complacent about existing accomplishments such as the titles of “Korea’s First,” “Pioneer in the Medical Equipment for Serious Patients,” and “Korea’s Unique,” we will continue to focus on technology development and advance into the global stage. Our efforts will also be made to realize the happiness of customers, shareholders, and employees as well as corporate growth.

Model OmniOx - High flow Nasal Cannula